Corticosteroids in essential hypertension: multiple candidate loci and phenotypic variation

Area of Science:

• Endocrinology
• Genetics
• Cardiovascular Medicine

Background:

• Adrenal steroid production, metabolism, and action are crucial in cardiovascular disease pathogenesis.
• Genetic variations in corticosteroid pathways may predispose individuals to cardiovascular conditions.

Purpose of the Study:

• To investigate the role of genetic variations in three key loci of corticosteroid function in cardiovascular disease.
• To explore the association between genetic polymorphisms and essential hypertension.

Main Methods:

• Studied the glucocorticoid receptor locus (Bcl1 polymorphism) and its effect on vasoconstrictor responses.
• Conducted a case-control study on essential hypertension patients to assess 11 beta-hydroxysteroid dehydrogenase activity.
• Analyzed gene homology between 11 beta-hydroxylase and aldosterone synthase, including a chimaeric gene in Dexamethasone Suppressible Hyperaldosteronism.

Main Results:

• Glucocorticoid receptor genotypes correlated with altered skin vasoconstrictor responses.
• Reduced 11 beta-hydroxysteroid dehydrogenase activity was observed in hypertensive patients, indicated by an elevated cortisol/cortisone metabolite ratio.
• A chimaeric gene involving 11 beta-hydroxylase and aldosterone synthase explains Dexamethasone Suppressible Hyperaldosteronism, though not phenotypic heterogeneity.

Conclusions:

• Three distinct genetic loci involved in corticosteroid pathways can independently influence cardiovascular phenotypes.
• Further research is needed to fully elucidate the role of these loci in pathophysiological changes, particularly hypertension.